Daicel Corp. (4202) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

823.3 k

Shareholding (Jun 2020)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 9.84%

High Debt Company with a Debt to Equity ratio (avg) at times

Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.84%

With a fall in Net Profit of -21.37%, the company declared Very Negative results in Jun 25

With ROCE of 10.60%, it has a very attractive valuation with a 0.95 Enterprise value to Capital Employed

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

JPY 386,335 Million (Mid Cap)

P/E

6.00

Industry P/E

Dividend Yield

0.04%

Debt Equity

0.64

Return on Equity

13.78%

Price to Book

1.07

Revenue and Profits:

Net Sales:

139,270 Million

(Quarterly Results - Jun 2025)

Net Profit:

9,922 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-3.18%

6 Months

10.92%

1 Year

-2.97%

2 Years

-0.11%

3 Years

32.72%

4 Years

67.77%

5 Years

86.18%

Daicel Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Daicel Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,315.00

Daicel Corp., a midcap specialty chemicals firm, faced a notable stock decline of 6.06%, reaching an intraday low of JPY 1,315.00. The company has struggled with financial performance, reporting consecutive quarterly losses and a significant drop in net profit, while its debt-to-equity ratio stands at 0.64.

Daicel Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,301.00

Daicel Corp., a midcap specialty chemicals company, faced a notable stock decline of 5.04%, reaching an intraday low of JPY 1,301.00. The company has struggled financially, with a year-to-date loss of 6.86% and negative net profit results for the past two quarters, highlighting ongoing challenges.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.28%

EBIT Growth (5y)

15.53%

EBIT to Interest (avg)

31.69

Debt to EBITDA (avg)

2.55

Net Debt to Equity (avg)

0.60

Sales to Capital Employed (avg)

0.86

Tax Ratio

22.93%

Dividend Payout Ratio

33.07%

Pledged Shares

Institutional Holding

0.01%

ROCE (avg)

9.84%

ROE (avg)

13.94%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.92

EV to EBIT

8.98

EV to EBITDA

5.35

EV to Capital Employed

0.95

EV to Sales

0.93

PEG Ratio

Dividend Yield

0.04%

ROCE (Latest)

10.60%

ROE (Latest)

15.43%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2020

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -9.56% vs 7.79% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 70.98% vs -52.01% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "139,270.00",
          "val2": "153,986.00",
          "chgp": "-9.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22,829.00",
          "val2": "28,924.00",
          "chgp": "-21.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "766.00",
          "val2": "635.00",
          "chgp": "20.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1,045.00",
          "val2": "-8,385.00",
          "chgp": "112.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9,922.00",
          "val2": "5,803.00",
          "chgp": "70.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.70%",
          "val2": "115.40%",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 5.10% vs 3.72% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -10.73% vs 35.79% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "586,531.00",
          "val2": "558,056.00",
          "chgp": "5.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "102,384.00",
          "val2": "96,096.00",
          "chgp": "6.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,983.00",
          "val2": "1,668.00",
          "chgp": "18.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8,385.00",
          "val2": "-2,174.00",
          "chgp": "-285.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50,477.00",
          "val2": "56,545.00",
          "chgp": "-10.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.00%",
          "val2": "111.80%",
          "chgp": "-0.78%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

139,270.00

153,986.00

-9.56%

Operating Profit (PBDIT) excl Other Income

22,829.00

28,924.00

-21.07%

Interest

766.00

635.00

20.63%

Exceptional Items

1,045.00

-8,385.00

112.46%

Consolidate Net Profit

9,922.00

5,803.00

70.98%

Operating Profit Margin (Excl OI)

93.70%

115.40%

-2.17%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -9.56% vs 7.79% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 70.98% vs -52.01% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

586,531.00

558,056.00

5.10%

Operating Profit (PBDIT) excl Other Income

102,384.00

96,096.00

6.54%

Interest

1,983.00

1,668.00

18.88%

Exceptional Items

-8,385.00

-2,174.00

-285.69%

Consolidate Net Profit

50,477.00

56,545.00

-10.73%

Operating Profit Margin (Excl OI)

104.00%

111.80%

-0.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 5.10% vs 3.72% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -10.73% vs 35.79% in Mar 2024

All Annual Results

Company CV

About Daicel Corp.

Daicel Corp.

Specialty Chemicals

No Details Available.

Company Coordinates

No Company Details Available

Daicel Corp.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

High Management Efficiency with a high ROCE of 9.84%

High Debt Company with a Debt to Equity ratio (avg) at times

Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.84%

With a fall in Net Profit of -21.37%, the company declared Very Negative results in Jun 25

With ROCE of 10.60%, it has a very attractive valuation with a 0.95 Enterprise value to Capital Employed

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Daicel Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,315.00

Daicel Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,301.00

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2020

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Mar'25

About Daicel Corp.

Company Coordinates